![Natalie L. McClure](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Natalie L. McClure
Keine laufenden Positionen mehr
Karriereverlauf von Natalie L. McClure
Ehemalige bekannte Positionen von Natalie L. McClure
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Cerimon Pharmaceuticals, Inc.
![]() Cerimon Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Cerimon Pharmaceuticals, Inc. developed and distributed biopharmaceutical products. It developed Simulect, a monoclonal antibody for the treatment of moderate-to-severe and steroid-refractory ulcerative colitis; diclofenac sodium, a non-steroidal anti-inflammatory drug that are used to treat various pains, included pain due to musculoskeletal injuries and lower back pain; and topical diclofenac sodium patch products. The company was founded by Paul J. Sekhri, Ansbert Gadicke, and Luke Evnin in November 2004 and was headquartered in South San Francisco, CA. | General Counsel | 01.06.2005 | 01.06.2008 |
Matrix Pharmaceuticals, Inc. | General Counsel | - | - |
IntraBiotics Pharmaceuticals, Inc.
![]() IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology IntraBiotics, a developer of antibiotics and antifungals is focused on one drug candidate, iseganan hydrochloride oral solution, which would be used for the prevention of ventilator-associated pneumonia and to help cystic fibrosis patients fight respiratory infections. | General Counsel | - | - |
Tularik, Inc.
![]() Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Compliance Officer | - | - |
General Counsel | - | - | |
Amgen SF LLC
![]() Amgen SF LLC Pharmaceuticals: MajorHealth Technology Part of Amgen, Inc., Amgen SF LLC is a pharmaceutical company that manufactures pharmaceutical products. The company is based in Thousand Oaks, CA. | General Counsel | - | - |
ADAMAS PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 07.07.2011 | 02.10.2012 |
General Counsel | 07.07.2011 | 12.03.2014 | |
Corporate Officer/Principal | 12.03.2014 | - |
Ausbildung von Natalie L. McClure
Stanford University | Doctorate Degree |
University of Michigan | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 9 |
Operativ
General Counsel | 6 |
Doctorate Degree | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 6 |
---|---|
Cerimon Pharmaceuticals, Inc.
![]() Cerimon Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Cerimon Pharmaceuticals, Inc. developed and distributed biopharmaceutical products. It developed Simulect, a monoclonal antibody for the treatment of moderate-to-severe and steroid-refractory ulcerative colitis; diclofenac sodium, a non-steroidal anti-inflammatory drug that are used to treat various pains, included pain due to musculoskeletal injuries and lower back pain; and topical diclofenac sodium patch products. The company was founded by Paul J. Sekhri, Ansbert Gadicke, and Luke Evnin in November 2004 and was headquartered in South San Francisco, CA. | Health Technology |
Adamas Pharmaceuticals LLC
![]() Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Adamas Pharmaceuticals, Inc. engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products include GOCOVRI, ADS-5012, ADS-4101, and Namzaric. GOCOVRI is indicated for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy. ADS-5102 is a treatment for walking impairment in patients with multiple sclerosis. ADS-401 treats partial onset seizures in patients with epilepsy. Namzaric is a drug treatment for moderate to severe Alzheimer's disease. The company was founded by Gregory T. Went on November 15, 2000 and is headquartered in Emeryville, CA. | Health Technology |
Amgen SF LLC
![]() Amgen SF LLC Pharmaceuticals: MajorHealth Technology Part of Amgen, Inc., Amgen SF LLC is a pharmaceutical company that manufactures pharmaceutical products. The company is based in Thousand Oaks, CA. | Health Technology |
Tularik, Inc.
![]() Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Commercial Services |
IntraBiotics Pharmaceuticals, Inc.
![]() IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology IntraBiotics, a developer of antibiotics and antifungals is focused on one drug candidate, iseganan hydrochloride oral solution, which would be used for the prevention of ventilator-associated pneumonia and to help cystic fibrosis patients fight respiratory infections. | Health Technology |
Matrix Pharmaceuticals, Inc. |
- Börse
- Insiders
- Natalie L. McClure
- Erfahrung